Device type · FFT
Electrode, Ph, Stomach
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
FFT
Gastroenterology & Urology
Device class
Class I
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
624
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Electrode, Ph, Stomach
- Product code
- FFT
- Device class
- Class I
- Review panel
- Gastroenterology & Urology
- Regulation
- 21 CFR 876.1400
- Specialty
- GI, Urology & Nephrology, Gastroenterology
- FDA record
- Classification database entry for FFT
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
624
Received Nov 1, 2025 to Nov 19, 2026. Includes 9 of another or unstated type.
Malfunction reports
468
75% of reports
Injury reports
147
24% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 7 | 5 | 0 | 0 |
| Jan 24 | 24 | 2 | 0 | 0 |
| Feb 24 | 13 | 4 | 0 | 0 |
| Mar 24 | 9 | 2 | 0 | 0 |
| Apr 24 | 16 | 2 | 0 | 0 |
| May 24 | 6 | 5 | 0 | 0 |
| Jun 24 | 11 | 2 | 0 | 0 |
| Jul 24 | 15 | 6 | 0 | 0 |
| Aug 24 | 20 | 7 | 0 | 0 |
| Sep 24 | 18 | 8 | 0 | 0 |
| Oct 24 | 18 | 8 | 0 | 0 |
| Nov 24 | 18 | 7 | 0 | 0 |
| Dec 24 | 11 | 7 | 0 | 0 |
| Jan 25 | 26 | 14 | 0 | 0 |
| Feb 25 | 26 | 4 | 0 | 0 |
| Mar 25 | 35 | 18 | 0 | 0 |
| Apr 25 | 54 | 11 | 0 | 0 |
| May 25 | 28 | 10 | 0 | 0 |
| Jun 25 | 38 | 14 | 0 | 0 |
| Jul 25 | 33 | 13 | 0 | 0 |
| Aug 25 | 42 | 12 | 0 | 0 |
| Sep 25 | 53 | 15 | 0 | 0 |
| Oct 25 | 31 | 4 | 0 | 0 |
| Nov 25 | 41 | 21 | 0 | 0 |
| Dec 25 | 42 | 9 | 0 | 0 |
| Jan 26 | 40 | 8 | 0 | 0 |
| Feb 26 | 33 | 17 | 0 | 0 |
| Mar 26 | 35 | 3 | 0 | 0 |
| Apr 26 | 31 | 15 | 0 | 0 |
| May 26 | 67 | 15 | 0 | 0 |
| Jun 26 | 46 | 7 | 0 | 0 |
| Jul 26 | 32 | 11 | 0 | 1 |
| Aug 26 | 31 | 15 | 0 | 0 |
| Sep 26 | 48 | 21 | 0 | 5 |
| Oct 26 | 22 | 5 | 0 | 3 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Separation Failure280
- Positioning Failure277
- Failure to Transmit Record19
- Break13
- Insufficient Device Problem Information10
- Entrapment of Device9
- Activation, Positioning or Separation Problem8
- Difficult or Delayed Separation7
- Adverse Event Without Identified Device or Use Problem5
- Activation Problem2
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions329
- Foreign Body In Patient189
- Airway Obstruction80
- Insufficient Information15
- Laceration(s) of Esophagus11
- Pain10
- Hemorrhage/Blood Loss/Bleeding9
- Dysphagia/ Odynophagia6
- Aspiration/Inhalation5
- Chest Pain4
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3090-2026 · Started Aug 6, 2026 · Posted by FDA Sep 11, 2026
Reason given: Capsule may fail to attach to the esophagus or detach from the delivery device. Risks include patient aspiration/inhalation, perforation of esophagus, obstruction of the airway, hemorrhage/blood loss/bleeding, laceration of the esophagus, a delay in diagnosis, and foreign bodies remaining in the patient.
Cause as FDA categorized it: Nonconforming Material/Component
Z-2047-2025 · Started Jun 3, 2025 · Posted by FDA Jul 10, 2025
Reason given: It has been determined that misapplied adhesive on the Bravo CF capsule delivery device may lead to its malfunction. Specifically, the misapplied adhesive may prevent the capsule from attaching to the patient's esophagus or detaching from the delivery device.
Cause as FDA categorized it: Process control
Z-1334-2021 · Started Feb 26, 2021
Reason given: The capsule may fail to attach to the esophageal mucosa, which in turn may lead to the aspiration of the capsule. In the event of capsule aspiration, immediate intervention to remove the capsule is required. Potential outcomes following capsule aspiration include low oxygen saturation, intervention to retrieve the...
Cause as FDA categorized it: Process change control
Z-1335-2021 · Started Feb 26, 2021
Reason given: The capsule may fail to attach to the esophageal mucosa, which in turn may lead to the aspiration of the capsule. In the event of capsule aspiration, immediate intervention to remove the capsule is required. Potential outcomes following capsule aspiration include low oxygen saturation, intervention to retrieve the...
Cause as FDA categorized it: Process change control
Z-1619-2016 · Started Apr 15, 2016 · Posted by FDA May 6, 2016
Reason given: Potential of an allergic reaction in a patient with nickel sensitivity.
Cause as FDA categorized it: Device Design
Z-1620-2016 · Started Apr 15, 2016 · Posted by FDA May 6, 2016
Reason given: Potential of an allergic reaction in a patient with nickel sensitivity.
Cause as FDA categorized it: Device Design
Z-0517-2008 · Started Dec 3, 2007 · Posted by FDA May 7, 2008
Reason given: Unable to detach from source: The capsule may not detach from the delivery system following attachment to the esophageal wall.
Cause as FDA categorized it: Labeling Change Control
Medtronic Gastroenterology / Urology
Z-0830-06 · Started Jan 25, 2006 · Posted by FDA May 3, 2006
Reason given: Lot 0001491 has a manufacturing defect in the sensor spacing. Sensors have been placed 5 cm apart instead of 15 cm apart. Medtronic has determined that patient safety is not compromised. Clinicians however should review and reassess the results of any patient studies for which catheters from lot 0001491 were used.
Cause as FDA categorized it: Other
Showing the 8 newest of 11 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.